 1. Patient has concurrent strong opioid for cancer pain, such as morphine, hydromorphone, oxycodone, meperidine, fentanyl, oral transmucosal fentanyl citrate OTFC, sufentanil, methadone, levorphanol, transdermal fentanyl. 